News
Research co-funded by Parkinson's UK finds a new way to potentially improve diagnosis and monitoring of Parkinson's.
We've supported the principle that everyone in Scotland who needs it should have a legal right to palliative care. However, the new law would need additional funding and to be on the right terms for people with Parkinson's and their families.
We're providing £1.6m through our Virtual Biotech programme to develop a potential new treatment targeting mitochondria to protect brain cells in Parkinson's patients.
A partnership involving Parkinson's UK has been recognised at the Made with Patients awards, organised by Patient Focused Medicines Development.
Campaigners are calling for the prescription charge exemption list in England to be reviewed following the price rise.
We're providing £2.1million through our Virtual Biotech programme to develop a potential new drug which holds promise for protecting brain cells in Parkinson's.
The TOP HAT trial is closing early and we have an important update on next steps.
Parkinson's UK has funded two future leaders in Parkinson's research who are pushing forward our understanding of the early stages and causes of Parkinson's.
Early research shows transplanting gut bacteria from healthy individuals to people with Parkinson's, called a faecal microbiota transplant, is safe and may ease motor symptoms.